Diabetes Flashcards Preview

Pharmacology Drugs > Diabetes > Flashcards

Flashcards in Diabetes Deck (28)
Loading flashcards...
1
Q

What is the role of insulin in the body?

A
  • Stimulates uptake of glucose into liver, muscle and adipose tissue
  • Decreases hepatic glucose output via inhibition of gluconeogenesis
  • Inhibits glycogenolysis
  • Promotes uptake of fats
  • Ideal insulin treatment would be to reinstate the normal daily insulin profile to prevent bot hyperglycaemia and hypoglycaemia
2
Q

What is the profile of type 1 diabetic?

A
  • Poorly controlled diabetes
  • Has a high variability of glucose concentration even with treatment
  • Insulin can be given post-prandially or generally through the day
3
Q

What are the types of insulin available?

A
  • Human short acting insulins
  • Human rapid acting insulin analogues
  • Isophane intermediate acting insulin
  • Long acting basal analogue insulins
  • Very long acting basal analogue insulins
4
Q

What are the 6 main insulin categories?

A
  • Ultrafast acting
  • Rapid Acting: rapid onset of action 5-15 mins. Inject just before eating and peaks around 60 mins. Duration is between 4 to 6 hours.
  • Short Acting: starts to work 30-60 mins. Need to inject at least 15-30 mins before eating several times daily to cover meals Peaks 2-3 hours. Duration is 8-10 hours
  • Intermediate Acting: slower onset 2-4 hours. Peaks 4-8 hours. Duration up to 12-20 hours.
  • Long Acting: slow onset 2-6 hours. Duration is up to 24 hours.
  • Very Long Acting: Very long up to 50+ hours
5
Q

What are some adverse effects of insulin?

A
Hypoglycaemia - too much insulin
Hyperglycaemia - too little insulin 
Lipodystrophy (lipohypertrophy or lipoatrophy)
Painful injections
Insulin allergies
6
Q

Why does blood glucose rise?

A
  • Inability to produce insulin due to beta cell failure and/or
  • Insulin production adequate but insulin resistance prevents insulin working effectively
7
Q

How is Type 2 diabetes treated?

A
  • Lifestyle methods plus non-insulin therapies such as Biguanides, Sulphonylureas, Thiazolidinedione, DPP4 inhibitors, Alpha Glucosidase inhibitors, SGLT2s, GLP1 analogues and Insulin
  • Weight gain and hypoglycaemia are important factors in patient adherence and quality of life. Compliance to treatment is a massive issue
8
Q

What is the target HbA1c in diabetes treatments?

A

6.5% - 7.5%.

9
Q

What are the effects of metformin?

A
  • Anti-hyperglycaemic effect by lowering basal and postprandial blood-glucose concentrations
  • Decreases gluconeogenesis (hepatic glucose production)
  • Acts In the presence of endogenous Insulin
  • Decrease insulin resistance leading to increased glucose use by tissues
  • Decrease weight gain
  • Decrease In cardiovascular events
  • Can be combined with all other diabetes medications
10
Q

What are some side effects of Metformin?

A
  • GI symptoms
  • Lactic acidosis rare
  • Vitamin B12 deficiency
11
Q

What are contraindications to Metformin?

A
  • CKD <30ml/min

- Metabolic acidosis

12
Q

What are some examples of Sulfonylureas?

A
  • Glicazide

- Glimepiride

13
Q

What are the effects of Sulfonylureas?

A
  • Stimulate beta cells to release insulin

- Extensive use decreases macrovascular risk

14
Q

What are the side effects of Sulfonylureas?

A
  • Weight gain

- Hypoglycaemia

15
Q

What are the effects of Acarbose?

A
  • Inhibits breakdown of carbohydrate to glucose by blocking action of the enzyme alpha Glucosidase
  • Modest reduction in HbA1c
  • Rarely used
16
Q

What are the side effects of Acarbose?

A
  • Flatulence
  • Loose stools
  • Diarrhoea
17
Q

What are the types of Glucagon like peptide 1 receptor agonists?

A
  • Exanatide
  • Liraglutide
  • Lixisenatide
18
Q

What are the physiological effects of Glucagon-like peptide-1 receptor agonists? (Exanatide, Liraglutide, Lixisenatide)

A
  • Decrease food intake through increase satiety
  • Decrease gastric emptying
  • Increase insulin biosynthesis
  • Increase glucose uptake in muscle
  • Decrease glucose producton from liver
19
Q

What are the side effects of Glucagon-like peptide-1 receptor agonists?

A
  • Gastrointestinal symptoms, nausea, loose stools or diarrhoea
  • Gastro oesophageal reflux
  • Low risk of hypoglycaemia
  • Occasional painful to inject
20
Q

When are Glucagon-like peptide-1 receptor agonists not used?

A

-Avoid if eGFR <30ml/min

21
Q

What are the general effects of Glucagon-like peptide-1 receptor agonists?

A
  • Increase insulin secretion from beta cells

- Decreases production of glucagon rom alpha cells

22
Q

What are the effects of Gliptins or DPP-4 inhibitors?

A
  • Inhibition of DPP-4 enzyme activity increasing post prandial active GLP-1 concentrations that is naturally occurring due to less breakdown of GLP-1
  • Weight neural
  • Modest HbA1c reduction
23
Q

What are the side effects of Gliptins or DPP-4 inhibitors?

A
  • GI symptoms

- Low risk of hypoglycaemia

24
Q

What are the effects of Glifozins?

A
  • Reversibly inhibits sodium-glucose co-transporter 2 in the renal proximal convoluted tubule to reduce glucose reabsorption and increase urinary glucose excretion
  • Can be used for patients with Type 1 and Type 2 diabetes as add on therapy
25
Q

What are the side effects of Glifozins?

A
  • Increased risk of lower urinary tract symptoms including genital and urinary symptoms especially in women
  • Polyuria
  • Hypoglycaemia risk low
26
Q

What are the effects of Glitazone?

A
  • Increased sensitivity in muscle and adipose tissue
  • Decreased hepatic glucose output
  • Bond to and activate one or more peroxisome proliferator-activated receptors
  • Can be used in combination with other oral agents
  • Cardiovascular concerns with Rosiglitazone
27
Q

What are some common side effects of Piogliatozone?

A
  • CVS concerns
  • Weight gain
  • Fluid retention
  • Heart failure
  • Bone metabolism
  • Bladder cancer
28
Q

What are examples of Glitazones?

A
  • Rosiglitazone

- Pioglatizone